Not too little, not too much… a lesson for cancer prevention from ancient civilisations
“If we could give every individual the right amount of nourishment and exercise, not too little and not too much, we would have found the safest way to health.” This…
Can gene therapy be made to work against solid tumours?
Gene therapy to treat cancer has been on the research agenda for three decades, with the first examples having been developed in the 1990s, according to Hrvoje Miletic, Senior Consultant…
José Baselga: A giant of medical oncology
José Baselga, one of the most high profile oncologists of recent times, has died at the age of 61. His fame in the cancer world is confirmed by the volume…
NEWS
Immunotherapy plus chemo: benefits in lung cancer neoadjuvant treatment
Adding a check point inhibitor to chemotherapy as neoadjuvant treatment for resectable non-small cell lung cancer (NSCLC) produced significant improvements of pathological complete response (pCR) in comparison to chemotherapy alone.…
SPCC Strategic Plan 2020-2022
SPCC wants to confirm and broaden its activity as an internationally recognised and highly respected provider of independent, evidence-based medical education in the cancer field and to increase knowledge in…
How can we best exploit cancer registries to the benefit of clinical research?
The Covid-19 pandemic has brought the role of clinical data registries to the fore once again. Such registries use observational study methods to collect data about the treatment, outcomes, and…
From 1918 to 2020, the lessons of pandemics remain
From 1918 to 2020, the lessons of pandemics remain: health systems must be kept strong, and international health cooperation underpinned “The new normal” and “unprecedented times” are phrases all of…
The European Parliament in Brussels lit up in gold in support of Childhood Cancer Awareness Month!
The year 2020 is proving to be challenging as the world is confronted with an extraordinary global health emergency and everyone’s attention is focused on one disease only: COVID-19. We…
CONTENTS
ARTICLES
Older, frail patients are still being let down by the regulators
Hans Wildiers is frustrated. “This drug is well-tolerated in older persons – this is a very frequent conclusion in publications. And it is often not a correct conclusion,” says the…
Don't miss our newsletter
Would you like to receive our bimonthly e-newsletter with the latest news from Cancer World magazine?
Next event
- 6th ESO-ESMO Latin-American Masterclass in Clinical Oncology
- ESO-ESMO Baltic and Eurasia Masterclass in Clinical Oncology
- 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology